| MYRIAD GENETICS DL-,01 |
| USA |
| Gesundheit |
| US62855J1043 / 897518 |
| MYD (Frankfurt) / MYGN (NASDAQ) |
| FRA:MYD, ETR:MYD, MYD:GR, NASDAQ:MYGN |
| - |
| https://myriad.com/ |
|
Myriad Genetics Inc. is a biotechnology company sp..
>Volltext.. |
| 397.16 Mio. EUR |
| 454.24 Mio. EUR |
| 693.56 Mio. EUR |
| -21.85 Mio. EUR |
| -336.57 Mio. EUR |
| -3.64 EUR |
| 178.41 Mio. EUR |
| 122.19 Mio. EUR |
| -1.85 Mio. EUR |
| 0.98 |
| -4.92% |
| -227.6% |
| - |
| - |
| - |
| - |
| MYRIAD GENETICS |
| 12.02.26 |